Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology

NCT03917563 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT03917563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03917563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 20, 2019
Completion date
April 20, 2024
Enrollment
1,050 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-valvular atrial fibrillation